We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ANDA Filers in U.S. Should Follow ICH Stability Testing Guidelines
ANDA Filers in U.S. Should Follow ICH Stability Testing Guidelines
July 10, 2013
The U.S. Food and Drug Administration has adopted international recommendations for abbreviated new drug application (ANDA) stability testing, brushing aside complaints from generic drugmakers that the guidelines are heavy-handed.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor